Integra LifeSciences Holdings Corporation (IART) Q3 2024 Earnings Call Transcript
…
22,900€
-2,55%
Echtzeit-Aktienkurs Integra LifeSciences Holdings Corp
Bid:
Ask:
Nachrichten zur Integra LifeSciences Holdings Corp Aktie
Integra LifeSciences Holdings Corporation 2024 Q3 - Results - Earnings Call Presentation
…
Amniotic Products Market: $900M to $1,289M Growth Forecast (2023-2028) | MarketsandMarkets™
Chicago, Aug. 16, 2024 (GLOBE NEWSWIRE) -- The "Amniotic Products Market Size, Share & Trends by Type (Cryopreserved…
Integra LifeSciences Holdings Corporation (IART) Q2 2024 Earnings Call Transcript
…
Integra LifeSciences Reports Second Quarter 2024 Financial Results
PRINCETON, N.J., July 29, 2024 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ: IART), a leading global medical…
Integra LifeSciences Holdings Q2 2024 Earnings Preview
…
Integra LifeSciences Still Underperforming As Manufacturing Issues Linger
…
Integra LifeSciences Holdings Corporation (IART) Q1 2024 Earnings Call Transcript
…
Integra LifeSciences Holdings Corporation 2024 Q1 - Results - Earnings Call Presentation
…
Integra LifeSciences revenue tops consensus in Q1, earnings in-line By Investing.com
Integra LifeSciences revenue tops consensus in Q1, earnings in-line…
Integra LifeSciences to Reschedule the First Quarter 2024 Financial Results Conference Call to May 6, 2024
PRINCETON, N.J., April 18, 2024 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ: IART), a leading global medical technology…
Integra LifeSciences (IART) Introduces MicroMatrix Flex
Integra LifeSciences (IART) MicroMatrix Flex has a flexible tip that delivers a flowable version of the Urinary Bladder Matrix (UBM)…
Truist cuts Integra LifeSciences target to $41 on outlook concerns By Investing.com
Truist cuts Integra LifeSciences target to $41 on outlook concerns…
Integra LifeSciences Holdings Corporation (IART) Q4 2023 Earnings Call Transcript
…
Integra LifeSciences (IART) Misses Q4 Earnings and Revenue Estimates
Integra (IART) delivered earnings and revenue surprises of -1.11% and 0.44%, respectively, for the quarter ended December 2023. Do the…
[Latest] Global Medical Implant Market Size/Share Worth USD 203.6 Billion by 2032 at a 6.8% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth, Growth Rate, Value)
[220+ Pages Latest Report] According to a market research study published by Custom Market Insights, the demand analysis of Global…
Global Veterinary Equipment and Supplies Market Size To Worth USD 4.1 Billion By 2032 | CAGR of 6.92%
The Veterinary Equipment and Supplies Market Size was valued at USD 2.1 Billion in 2022 and the Worldwide Veterinary Equipment…
Tissue Engineered - Skin Substitutes Market Size by Segments, Share, Regulatory, Reimbursement and Forecast to 2033, Featuring Integra LifeSciences, LifeNet Health, MiMedx & Allergan
Dublin, Jan. 08, 2024 (GLOBE NEWSWIRE) -- The "Tissue Engineered - Skin Substitutes Market Size by Segments, Share,…
Integra LifeSciences to Present at the 42nd Annual J.P. Morgan Healthcare Conference
PRINCETON, N.J., Jan. 05, 2024 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ: IART), a leading global medical technology…
Integra LifeSciences: M&A Masks Operational Struggles
…
INTEGRA ALERT: Bragar Eagel & Squire, P.C. is Investigating Integra LifeSciences Holdings Corp. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
NEW YORK, Dec. 14, 2023 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights…
Integra LifeSciences to acquire Acclarent
…
Integra LifeSciences Appoints Jeff Graves, Ph.D., to Board of Directors
PRINCETON, N.J., Dec. 12, 2023 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq: IART), a leading global medical technology…
Global Wound Care Biologics Market Size To Worth USD 2.16 Billion By 2032 | CAGR of 5.6%
The Global Wound Care Biologics Market Size was valued at USD 1.25 Billion in 2022 and the Worldwide Wound Care…
Global Diabetic Ulcers Treatment Market Size To Grow USD 16.3 Billion by 2032 | CAGR of 5.2%
The Global Diabetic Ulcers Treatment Market Size was valued at USD 9.8 Billion in 2022 and the Worldwide Diabetic Ulcers…
Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Integra LifeSciences Holdings Corporation (IART)
LOS ANGELES, Nov. 09, 2023 (GLOBE NEWSWIRE) -- Glancy Prongay & Murray LLP (“GPM”) reminds investors of the…
FILING DEADLINE--Kuznicki Law PLLC Announces Class Action on Behalf of Shareholders of Integra LifeSciences Holdings Corporation - IART
CEDARHURST, N.Y., Nov. 08, 2023 (GLOBE NEWSWIRE) -- The securities litigation law firm of Kuznicki Law PLLC issues…
SHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders of Integra LifeSciences Holdings Corporation of a Class Action Lawsuit and a Lead Plaintiff Deadline of November 13, 2023 – (NASDAQ: IART)
NEW YORK, Nov. 08, 2023 (GLOBE NEWSWIRE) -- The Gross Law Firm issues the following notice to shareholders…
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Integra LifeSciences Holdings Corporation - IART
NEW YORK, Nov. 05, 2023 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of…
ROSEN, LEADING INVESTOR COUNSEL, Encourages Integra LifeSciences Holdings Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action – IART
NEW YORK, Nov. 05, 2023 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm,…
INTEGRA ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against Integra LifeSciences Holdings Corp. and Encourages Investors to Contact the Firm
NEW YORK, Nov. 03, 2023 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights…
ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Integra LifeSciences Holdings Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action – IART
NEW YORK, Nov. 02, 2023 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm,…
Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Integra LifeSciences Holdings Corporation (IART)
LOS ANGELES, Nov. 01, 2023 (GLOBE NEWSWIRE) -- Glancy Prongay & Murray LLP (“GPM”) reminds investors of the…
ROSEN, TOP RANKED INVESTOR COUNSEL, Encourages Integra LifeSciences Holdings Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action – IART
NEW YORK, Oct. 30, 2023 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law…
INTEGRA ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against Integra LifeSciences Holdings Corp. and Encourages Investors to Contact the Firm
NEW YORK, Oct. 29, 2023 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights…
ROSEN, NATIONAL TRIAL LAWYERS, Encourages Integra LifeSciences Holdings Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action – IART
NEW YORK, Oct. 27, 2023 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law…
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Integra LifeSciences Holdings Corporation - IART
NEW YORK, Oct. 27, 2023 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of…
Integra LifeSciences: Theres Value Here If They Can Stop The Unforced Errors
…
Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Integra LifeSciences Holdings Corporation (IART)
LOS ANGELES, Oct. 26, 2023 (GLOBE NEWSWIRE) -- Glancy Prongay & Murray LLP (“GPM”) reminds investors of the…
FILING DEADLINE--Kuznicki Law PLLC Announces Class Action on Behalf of Shareholders of Integra LifeSciences Holdings Corporation - IART
CEDARHURST, N.Y., Oct. 25, 2023 (GLOBE NEWSWIRE) -- The securities litigation law firm of Kuznicki Law PLLC issues…
Integra LifeSciences Holdings Corporation (IART) Q3 2023 Earnings Call Transcript
…
Integra LifeSciences Holdings Corporation 2023 Q3 - Results - Earnings Call Presentation
…
Integra LifeSciences Holdings misses Q3 top and bottom line estimates; updates FY23 outlook
…
INTEGRA ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against Integra LifeSciences Holdings Corp. and Encourages Investors to Contact the Firm
NEW YORK, Oct. 24, 2023 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights…
Integra LifeSciences Holdings Q3 2023 Earnings Preview
…
SHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders of Integra LifeSciences Holdings Corporation of a Class Action Lawsuit and a Lead Plaintiff Deadline of November 13, 2023 – (NASDAQ: IART)
NEW YORK, Oct. 20, 2023 (GLOBE NEWSWIRE) -- The Gross Law Firm issues the following notice to shareholders…
Kirby McInerney LLP Reminds Investors That a Class Action Lawsuit Has Been Filed on Behalf of Integra LifeSciences Holdings Corporation (IART) Investors and Encourages Investors to Contact the Firm Before November 13, 2023
NEW YORK, Oct. 20, 2023 (GLOBE NEWSWIRE) -- The law firm of Kirby McInerney LLP announces that a…
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against PacWest, Integra, and Enviva and Encourages Investors to Contact the Firm
NEW YORK, Oct. 19, 2023 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights…
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Integra LifeSciences Holdings Corporation - IART
NEW YORK, Oct. 19, 2023 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of…
Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Integra LifeSciences Holdings Corporation (IART)
LOS ANGELES, Oct. 19, 2023 (GLOBE NEWSWIRE) -- Glancy Prongay & Murray LLP (“GPM”) reminds investors of the…